Man Group PLC Sage Therapeutics, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 25,903 shares of SAGE stock, worth $148,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,903

Holding current value

$148,424

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $274,053 - $463,663	25,903 New	25,903 $281,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $436,865 - $639,876	-10,747 Reduced 11.76%	80,661 $3.79 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $3.41 Million - $4.26 Million	91,408 New	91,408 $3.84 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $2.89 Million - $3.88 Million	-89,674 Reduced 90.83%	9,053 $355,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $537,162 - $741,526	19,519 Added 24.64%	98,727 $3.19 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $2.43 Million - $3.62 Million	79,208 New	79,208 $2.62 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $170,587 - $216,847	-4,603 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $44,084 - $62,820	1,095 Added 31.21%	4,603 $204,000
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $642,644 - $928,485	-11,710 Reduced 76.95%	3,508 $200,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $2.38 Million - $3.26 Million	-33,714 Reduced 68.9%	15,218 $1.14 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $4.65 Million - $7.09 Million	-79,555 Reduced 61.92%	48,932 $4.23 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $2.66 Million - $4.03 Million	64,594 Added 101.1%	128,487 $7.85 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $689,673 - $1.15 Million	26,577 Added 71.22%	63,893 $2.66 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $975,813 - $2.88 Million	37,316 New	37,316 $1.07 Million
Q4 2019 Feb 18, 2020	SELL	$60.18 - $154.77 $979,670 - $2.52 Million	-16,279 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $1.98 Million - $2.68 Million	14,111 Added 650.88%	16,279 $2.28 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $1.74 Million - $2.02 Million	-11,047 Reduced 83.59%	2,168 $397,000
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $1.18 Million - $2.16 Million	13,215 New	13,215 $2.1 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $1.27 Million - $2.16 Million	-15,452 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $1.5 Million - $1.83 Million	10,848 Added 235.62%	15,452 $2.18 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $449,853 - $563,310	3,205 Added 229.09%	4,604 $721,000
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $212,857 - $269,069	1,399 New	1,399 $225,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account